Health professionals in B.C. are asking parents to be vigilant this respiratory season as ER and primary care centre visits ...

You hear about the flu vaccine, the COVID-19 vaccine, even the pneumonia vaccine, but in 2023, the FDA approved the first RSV ...

Northwell Health reports pediatricians emphasize vaccines' effectiveness and safety, urging parents to follow the recommended ...

GSK said on Friday a panel of the European Medicines Agency had backed the use of its respiratory syncytial virus (RSV) ...

You recently posted a couple of articles about the respiratory syncytial virus (RSV) vaccine and the benefits versus the ...

In a new study, adults 45 and up who got this seasonal virus had a higher risk of major heart issues, especially in the first ...

COVID-19, RSV, and influenza immunizations show continued safety and substantial effectiveness against hospitalization across various populations.

There is underreporting of adverse effects from vaccines; but, in the vast majority of cases, the side effects from the ...

A new study has found that a significant percentage of adults in the United States have at least one risk factor for severe respiratory syncytial virus (RSV), even as eligibility for the RSV ...

U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for infants would face fresh safety scrutiny following ...

Investing.com -- GSK plc (LSE:GSK) announced Friday that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended expanding the indication of its RSV ...